War on C Difficile Is Being Fought On Multiple Fronts

 
• By Bridget Silverman

Pivotal trials are underway for two microbiota restoration therapies, a narrow-spectrum antibiotic and a vaccine; funding from non-profits and new owners have revived stalled projects at Summit, Deinove and MGB Biopharma.

Clostridium difficile bacteria isolated on black background, 3D illustration. Bacteria which cause pseudomembraneous colitis and are associated with nosocomial antibiotic resistance - Illustration

More from R&D

More from Pink Sheet